Mutations in a multifunctional protein cause parkinsonism
LRRK2 gene may play a central role in the pathogenesis of several neurodegenerative disorders
A team of researchers at Mayo Clinic in Jacksonville, Fla., and colleagues in Canada and Germany have discovered a gene and six mutations of it that cause symptoms associated with Parkinsons disease and other neurodegenerative disorders. Their discovery will be reported in the Nov. 18 issue of the journal, Neuron. The team found a mutation of the gene, named LRRK2, in members of six families with many individuals affected by Parkinsons disease. Surprisingly, brain autopsy on deceased, affected family members who participated in this research indicate mutations in the LRRK2 gene play a central role in developing pathology characteristic of Parkinsons disease and other neurodegenerative disorders such as Alzheimers disease and amyotrophic lateral sclerosis (Lou Gehrigs disease).
For 14 years Mayo Clinic neurologist Dr. Zbigniew Wszolek has studied the two largest families in which a LRRK2 mutation was found. “The discovery of this gene will have major implications for the understanding of mechanisms leading to the development of these neurodegenerative diseases,” he says. “We also hope that continued study of this gene will lead to curative treatments for Parkinsons disease and other similar conditions.” Mayo Clinic neurologist Dr. Ryan Uitti has treated members of one of the six families with the gene mutation. “This finding is potentially a giant leap forward,” he says. “Many people with Parkinsons disease have dementia as well, and this may help to explain how that occurs.”
The discovery is the culmination of research into the cause of autosomal dominant, late- onset Parkinsons disease in the studied families. This team and others have previously narrowed a genetic cause for this form of inherited parkinsonism to a region of chromosome 12 called PARK8.
Mayo Clinic neuroscientist Matthew Farrer, Ph.D., and his team, continued to perform sophisticated genetic analyses on DNA collected from family members. Their work revealed the culprit gene and the multifunctional protein that it codes for.
Mayo Clinic neuropathologist Dr. Dennis Dickson performed brain tissue studies that revealed for the first time one gene was responsible for a range of pathology associated with a host of neurodegenerative disorders.
Dicksons studies revealed sufferers uniformly exhibited pathology consistent with Parkinsons disease. Some exhibited additional pathology associated with either diffuse Lewy body disease, Alzheimers disease or Lou Gehrigs disease.
Media Contact
More Information:
http://www.mayo.eduAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…